Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Beta Amino Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117550987B reveals CO2-based synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN113896662A details a high-yield rhodium-catalyzed synthesis for chiral aminocyclopropane intermediates, offering significant cost and supply chain advantages.
Patent CN1119321C details a scalable Reformatsky route for ethyl 3S-amino-4-pentynoate, offering high optical purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN104910034A details a novel ruthenium-catalyzed synthesis for high-purity alpha-beta-diamino acid derivatives, offering cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1511826A introduces a robust ketone-based route for beta-amino acids, offering significant cost reduction in API manufacturing and enhanced supply chain reliability for global pharma.
Patent CN105392891B enables high-yield production of optically active D/L amino acids with thiol groups. Enhances supply chain reliability and reduces manufacturing costs for peptide synthesis.
Patent CN102212041A details a cost-effective synthesis of chiral cyclic beta-amino aryl butyric acid derivatives with high optical purity suitable for pharmaceutical manufacturing.
Discover the one-pot synthesis of beta-C-glycosyl amino acids via patent CN120247956A. Enhanced stereoselectivity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN102212015A details a cost-effective chiral induction method for high-purity beta-amino acids, offering significant supply chain advantages for API manufacturing.
Discover advanced one-step synthesis of alpha beta diamino acid derivatives via patent CN102153488A. High yield, scalable pharma intermediate manufacturing solutions.
Patent CN107793351A reveals advanced C-H amination for beta amino acids. Enables cost reduction and scalable manufacturing for pharmaceutical intermediates supply chains globally.
Patent CN107793351B details a novel Pd-catalyzed route to diverse beta-amino acids, offering mild conditions and structural variety for API intermediate manufacturing.
Novel rhodium-catalyzed one-step synthesis offers high selectivity and supply chain stability for pharmaceutical intermediates manufacturing ensuring reliable sourcing for global drug development pipelines.
Novel magnesium-catalyzed asymmetric allylation for Sitagliptin intermediate. Reduces cost and improves supply chain reliability for pharmaceutical manufacturers.
Patent CN101402582A reveals a novel one-step four-component reaction for high-purity pharmaceutical intermediates. This method significantly reduces cost and improves supply chain reliability.
Novel chiral resolution method using aspartic acid eliminates chromatography, offering high purity and scalable production for pharmaceutical intermediates.
Patent CN106831474B reveals a one-step rhodium-catalyzed synthesis for anticancer intermediates, offering significant cost and supply chain advantages for global pharmaceutical manufacturers.
Patent CN106831474B details a rhodium-catalyzed synthesis of alpha-aryl-alpha,beta-diamino acid esters with high selectivity for anticancer drug manufacturing.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.